Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines.
about
Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA VaccineGenetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells.The extent of the uptake of plasmid into the skin determines the immune responses induced by a DNA vaccine applied topically onto the skin.Vaccination with a Sindbis virus-based DNA vaccine expressing antigen 85B induces protective immunity against Mycobacterium tuberculosis.Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccinesType I Interferons are essential for the efficacy of replicase-based DNA vaccines.Replicase-based plasmid DNA shows anti-tumor activity.Control of the rescue and replication of Semliki Forest virus recombinants by the insertion of miRNA target sequences.Modulation of SIV and HIV DNA vaccine immunity by Fas-FasL signalingAdjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune PotentiatorsSuperior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine.Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications.Control of solid tumor growth in mice using EGF receptor-targeted RNA replicase-based plasmid DNA.Antitumor activity of tumor-targeted RNA replicase-based plasmid that expresses interleukin-2 in a murine melanoma model.Role of TLR3 in the immunogenicity of replicon plasmid-based vaccines.Measles vaccination: new strategies and formulations.mRNA vaccination as a safe approach for specific protection from type I allergy.Three types of human CpG motifs differentially modulate and augment immunogenicity of nonviral and viral replicon DNA vaccines as built-in adjuvants.Nonspreading Rift Valley Fever Virus Infection of Human Dendritic Cells Results in Downregulation of CD83 and Full Maturation of Bystander Cells.Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis.Long-term protection in hamsters against human parainfluenza virus type 3 following mucosal or combinations of mucosal and systemic immunizations with chimeric alphavirus-based replicon particles.
P2860
Q27485003-0C56A465-5BB7-4E34-81D6-60A16DF08968Q33922779-650D02DE-1910-4722-94BA-D62ABD154B0EQ34025333-70FE3287-5233-4CF1-9D5C-DFF59B093DBFQ34111604-173958B7-FA97-4567-B6D2-821773AD8394Q34573907-5F9D5A04-3DA9-48C1-A8A1-AA13FC0DD142Q34705057-016247D3-9874-4525-8ED7-6BD625105E69Q34778611-258EA144-8EBA-4CEE-845B-BBF3E7FFE8A8Q35010110-DFEC46BD-6B8B-4E9F-95B7-4D993797E617Q35232840-C554148D-19B8-46AD-A818-8C226087AF52Q35826747-DB72B11E-C84B-4EB2-8804-F249D0E4EAA8Q35868091-A2016CCD-9222-4D7E-A070-A79980A51CFCQ35953762-48FAE193-1A86-48EC-B818-C2C02EAFDEA8Q36086315-CB8AFF84-2803-43BC-A4BF-493C041057B3Q36377208-D4DD5FFA-518D-40A5-A911-7F70E1EECC1EQ36471407-5227F102-E852-473A-AD1F-B34CF60C3C46Q37065888-DDCAC15F-6AB1-4711-AEFB-00ED32B30E78Q37127370-48C23570-D9AD-40DA-B49F-1390F5389D16Q37290110-40E47823-2CE3-41EA-8DA9-74DBCFCAB797Q37965722-A786F6DD-F8FB-48F5-A9C8-B9FA5751624EQ39265708-BC5EA5F8-87D8-48DF-8F2B-0C5E4F0D32E9Q40130716-328AE084-BE62-43F0-A3BF-D1DC0511096BQ40223076-68F704F9-616C-4C43-9AED-17BCDEA1193BQ45399630-F776FA8B-C19D-4540-B166-DEEA83BE68D2
P2860
Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Apoptosis is essential for the ...... replicase-based DNA vaccines.
@ast
Apoptosis is essential for the ...... replicase-based DNA vaccines.
@en
Apoptosis is essential for the ...... replicase-based DNA vaccines.
@nl
type
label
Apoptosis is essential for the ...... replicase-based DNA vaccines.
@ast
Apoptosis is essential for the ...... replicase-based DNA vaccines.
@en
Apoptosis is essential for the ...... replicase-based DNA vaccines.
@nl
prefLabel
Apoptosis is essential for the ...... replicase-based DNA vaccines.
@ast
Apoptosis is essential for the ...... replicase-based DNA vaccines.
@en
Apoptosis is essential for the ...... replicase-based DNA vaccines.
@nl
P2093
P2860
P50
P1433
P1476
Apoptosis is essential for the ...... l replicase-based DNA vaccines
@en
P2093
Leroy N Hwang
Stephan Frank
Steven E Finkelstein
P2860
P304
P356
10.1016/J.VACCINE.2003.10.013
P407
P577
2004-03-01T00:00:00Z